ATE464067T1 - Bindegewebs wachstumsfaktor (ctgf) - Google Patents

Bindegewebs wachstumsfaktor (ctgf)

Info

Publication number
ATE464067T1
ATE464067T1 AT96916841T AT96916841T ATE464067T1 AT E464067 T1 ATE464067 T1 AT E464067T1 AT 96916841 T AT96916841 T AT 96916841T AT 96916841 T AT96916841 T AT 96916841T AT E464067 T1 ATE464067 T1 AT E464067T1
Authority
AT
Austria
Prior art keywords
ctgf
growth factor
connective tissue
tissue growth
provides
Prior art date
Application number
AT96916841T
Other languages
English (en)
Inventor
Gary Grotendorst
Douglass Bradham
Original Assignee
Univ South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Florida filed Critical Univ South Florida
Application granted granted Critical
Publication of ATE464067T1 publication Critical patent/ATE464067T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
AT96916841T 1995-06-02 1996-05-31 Bindegewebs wachstumsfaktor (ctgf) ATE464067T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/459,717 US5770209A (en) 1991-08-30 1995-06-02 Acceleration of wound healing using connective tissue growth factor
PCT/US1996/008140 WO1996038172A1 (en) 1995-06-02 1996-05-31 Connective tissue growth factor

Publications (1)

Publication Number Publication Date
ATE464067T1 true ATE464067T1 (de) 2010-04-15

Family

ID=23825885

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96916841T ATE464067T1 (de) 1995-06-02 1996-05-31 Bindegewebs wachstumsfaktor (ctgf)

Country Status (11)

Country Link
US (4) US5770209A (de)
EP (2) EP0831885A4 (de)
JP (4) JPH11506449A (de)
CN (2) CN1195295A (de)
AT (1) ATE464067T1 (de)
AU (2) AU720268B2 (de)
BR (2) BR9609521A (de)
CA (2) CA2222609A1 (de)
DE (1) DE69638162D1 (de)
SG (1) SG108208A1 (de)
WO (2) WO1996038168A1 (de)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384634B2 (en) 1991-08-30 2008-06-10 University Of South Florida Connective tissue growth factor
US5408040A (en) * 1991-08-30 1995-04-18 University Of South Florida Connective tissue growth factor(CTGF)
US7026299B2 (en) 1994-07-12 2006-04-11 Human Genome Sciences, Inc. Connective tissue growth factor-2
US6638912B2 (en) * 1995-05-01 2003-10-28 The Regents Of The University Of California Peptide compositions mimicking TGF-β activity
AU763649B2 (en) * 1995-06-02 2003-07-31 University Of South Florida Connective tissue growth factor
JP4307552B2 (ja) 1996-03-15 2009-08-05 ミューニン コーポレイション 細胞外マトリックスシグナリング分子
US20090081228A1 (en) * 1996-03-15 2009-03-26 Munin Corporation Cyr61 compositions and methods
US7521540B2 (en) * 1996-03-15 2009-04-21 Munin Corporation CYR61 compositions and methods
US6790606B1 (en) 1996-03-15 2004-09-14 Munin Corporation Extracellular matrix signaling molecules
AU7610396A (en) * 1996-11-08 1998-06-03 Human Genome Sciences, Inc. Connective tissue growth factor-3
US20040132987A1 (en) 1996-11-08 2004-07-08 Human Genome Sciences, Inc. Connective tissue growth factor-3
CA2274122C (en) * 1996-12-06 2004-02-17 Osiris Therapeutics, Inc. Improved chondrogenic differentiation of human mesenchymal stem cells
DE19719652A1 (de) * 1997-05-09 1998-12-03 Merckle Gmbh Tissue-Faktor zur Förderung von Wundheilung
CA2294569A1 (en) * 1997-06-19 1998-12-23 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1998058063A1 (en) * 1997-06-19 1998-12-23 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a growth factor-like protein (as amended)
US5876730A (en) * 1997-08-07 1999-03-02 Childrens Hospital Research Foundation Heparin-binding growth factor (HBGF) polypeptides
JP4537507B2 (ja) * 1997-12-25 2010-09-01 アムジェン インコーポレイテッド 結合組織増殖因子に対するモノクローナル抗体及びその医薬用途
US6562618B1 (en) 1997-12-25 2003-05-13 Japan Tobacco, Inc. Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
US6451771B1 (en) 1999-02-12 2002-09-17 Nutramax Laboratories, Inc. Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals
US6797289B2 (en) * 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
ES2338946T3 (es) * 1998-02-13 2010-05-13 Nutramax Laboratories, Inc. Agentes y procedimientos para la proteccion, tratamiento y reparacion del tejido conjuntivo.
US20070141181A1 (en) * 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
EP1112088B1 (de) * 1998-09-08 2010-10-27 Henry Ford Health System Verfahren zum Nachweis von Bindegewebswachstumsfaktor zur Diagnose von Nierkrankheiten
US6348329B1 (en) * 1998-11-06 2002-02-19 Fibrogen, Inc. Nucleic acids encoding rat connective tissue growth factor (CTGF) and methods of use
US7115390B1 (en) 1998-12-14 2006-10-03 Fibrogen, Inc. Connective tissue growth factor fragments and methods and uses thereof
US6350472B1 (en) * 1998-12-14 2002-02-26 Steinbach, Pylant, And Hermann, L.L.C. Method of treating HIV infection with transdermal gel containing mammalian liver extract
MXPA01005949A (es) * 1998-12-14 2002-09-18 Univ Miami Fragmentos de factor de crecimiento de tejido conectivo y metodos y usos de los mismos.
KR100704537B1 (ko) * 1999-02-01 2007-04-09 제네틱스 인스티튜트, 엘엘씨 관절 연골의 치유 및 회복을 위한 조성물
JP2003527075A (ja) * 1999-03-25 2003-09-16 ハイセック,インコーポレーテッド ハイブリダイゼーションによる配列分析のための、溶液ベースの方法
US6555322B1 (en) 1999-08-27 2003-04-29 Fibrogen, Inc. α2-macroglobulin receptor as a receptor for CTGF
US20060052328A1 (en) * 2000-07-11 2006-03-09 Human Genome Sciences, Inc. Connective tissue growth factor-2
EP1373299A4 (de) * 2000-07-11 2005-01-19 Human Genome Sciences Inc Bindegewebs-wachstumsfaktor-2
US6939540B1 (en) * 2000-07-31 2005-09-06 Cornell Research Foundation, Inc. Method of enhancing bone density
US6599526B2 (en) * 2000-08-18 2003-07-29 The University Of North Texas Health Science Center At Fort Worth Pericardial anti-adhesion patch
AU2002224056A1 (en) * 2000-11-22 2002-06-03 Yamanouchi Pharmaceutical Co..Ltd. Novel polypeptide
WO2003024308A2 (en) * 2001-09-18 2003-03-27 Fibrogen, Inc. Methods of assaying connective tissue growth factor
EP1438067A4 (de) * 2001-09-24 2006-06-14 Verigen Ag Autologe wachstumsfaktor-cocktail-zusammensetzung, herstellungsverfahren und verwendung
JP4456796B2 (ja) * 2001-09-27 2010-04-28 株式会社林原生物化学研究所 コラーゲン産生増強剤の製造方法とその用途
US6965025B2 (en) 2001-12-10 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of connective tissue growth factor expression
BR0214832A (pt) * 2001-12-12 2004-08-31 Merck Patent Ges Mit Beschaenk Inibição de tristetraprolina para proteção do coração contra danos cardìacos
EP1616568A3 (de) 2002-04-30 2006-06-21 Alcon, Inc GSK-3- und CDK-Inhibitoren als Antiglaukomamittel
EP1497420A4 (de) * 2002-04-30 2005-04-27 Alcon Inc Mittel, die die aktivität und/oder expression von bindegewebe-wachstumsfaktor (ctgf) regulieren, hemmen oder modulieren, als einzigartige mittel sowohl zur senkung des augeninnendrucks als auch zur behandlung von glaukomatösen retinopathien/optischen neuropathien
US7462602B2 (en) * 2003-05-01 2008-12-09 University Of Florida Research Foundation, Inc. Anti-scarring ribozymes and methods
US7405274B2 (en) * 2003-06-04 2008-07-29 Fibrogen, Inc. Connective tissue growth factor antibodies
WO2005033136A1 (en) * 2003-09-29 2005-04-14 Children's Hospital, Inc. Unique integrin binding site in connective tissue growth factor (ctgf)
EP1687410A4 (de) * 2003-10-07 2008-04-09 Isis Pharmaceuticals Inc Für das nieren-targeting optimierte antisense-oligonukleotide
US20050191653A1 (en) * 2003-11-03 2005-09-01 Freier Susan M. Modulation of SGLT2 expression
CA2555789A1 (en) 2004-02-11 2005-08-25 Fibrogen, Inc. Ctgf as target for the therapy of diabetic nephropathy
MXPA06012576A (es) 2004-04-28 2007-01-31 Fibrogen Inc Tratamientos para cancer pancreatico.
WO2005120231A1 (en) * 2004-06-08 2005-12-22 Fibrogen, Inc. Connective tissue growth factor regulates intracellular signaling pathways
TWI386225B (zh) * 2004-12-23 2013-02-21 Alcon Inc 用於治療眼睛病症的結締組織生長因子(CTGF)RNA干擾(RNAi)抑制技術
US20060275797A1 (en) * 2005-03-21 2006-12-07 Alcon Manufacturing, Ltd. Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders
EP1891109A1 (de) 2005-05-05 2008-02-27 Fibrogen, Inc. Therapien von herzkreislauferkrankungen
WO2009070698A1 (en) * 2007-11-29 2009-06-04 The Trustees Of Columbia University In The City Of New York Microsphere skin treatment
US20100331249A1 (en) * 2008-07-23 2010-12-30 National Taiwan University Pharmaceutical composition for inhibiting peritoneal dissemination
CN107083386A (zh) * 2008-08-25 2017-08-22 埃克斯雷德制药有限公司 阻止结缔组织生长因子的反义核苷酸及其用途
US8946172B2 (en) 2008-08-25 2015-02-03 Excaliard Pharmaceuticals, Inc. Method for reducing scarring during wound healing using antisense compounds directed to CTGF
EP2342340A1 (de) 2008-09-22 2011-07-13 Rxi Pharmaceuticals Corporation Rna-interferenz bei hautindikationen
EP2221387A1 (de) 2009-02-19 2010-08-25 Université de la Méditerranée Fibroseanfälligkeitsgen und Verwendungen davon
JP5166360B2 (ja) * 2009-06-23 2013-03-21 株式会社島津製作所 マイクロ反応装置を用いた細胞運動評価方法
EP2448971A1 (de) 2009-07-02 2012-05-09 Fibrogen, Inc. Verfahren zur behandlung von muskeldystrophie
WO2011056234A1 (en) 2009-11-06 2011-05-12 Fibrogen, Inc. Treatment for radiation-induced disorders
US9095504B2 (en) 2010-03-24 2015-08-04 Rxi Pharmaceuticals Corporation RNA interference in ocular indications
CA2794189C (en) 2010-03-24 2022-01-11 Rxi Pharmaceuticals Corporation Rna interference in dermal and fibrotic indications
KR101249041B1 (ko) * 2010-04-28 2013-03-29 포항공과대학교 산학협력단 결합조직 성장인자를 이용한 약학적 조성물
WO2012061811A2 (en) 2010-11-05 2012-05-10 Fibrogen, Inc. Treatment method for lung remodeling diseases
WO2012100262A1 (en) 2011-01-21 2012-07-26 Fibrogen, Inc. Therapeutic method using anti - ctgf antibody
DK2670411T3 (da) 2011-02-02 2019-05-13 Excaliard Pharmaceuticals Inc Antisense-forbindelser rettet mod bindevævsvækstfaktor (CTGF) til anvendelse i en fremgangsmåde til behandling af keloider eller hypertrofiske ar
BR112014002347B1 (pt) 2011-08-05 2021-09-21 Inserm - Institut National De La Santé Et De La Recherche Médicale Método in vitro para determinar um risco de desenvolvimento de fibrose hepática ou cirrose
US9480449B2 (en) 2012-05-03 2016-11-01 Fibrogen, Inc. Methods for treating idiopathic pulmonary fibrosis
US9631013B2 (en) 2014-01-28 2017-04-25 Fibrogen, Inc. Therapeutic method for pancreatic cancer
KR20250162599A (ko) * 2018-11-08 2025-11-18 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. 부착 비의존성 세포 및 그 용도
CA3142092A1 (en) 2019-06-04 2020-12-10 Jiangsu Hengrui Medicine Co., Ltd. Anti-connective tissue growth factor antibody and application thereof
JP2022551086A (ja) * 2019-10-03 2022-12-07 ヴィトルヴィア ホールディングス インコーポレイテッド 結合組織修復の方法
US12472234B2 (en) 2021-09-10 2025-11-18 Bjorn Eek Treatment of connective tissue injuries
EP4238558A1 (de) * 2022-03-02 2023-09-06 Bjorn Eek Behandlung von bindegewebsverletzungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1989A (en) 1841-02-20 Stump-extractor
US5356630A (en) * 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
US5149691A (en) * 1991-03-12 1992-09-22 Creative Biomolecules, Inc. Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
FR2678283A1 (fr) * 1991-06-25 1992-12-31 Centre Nat Rech Scient Sequences de nucleotides, sequences d'acides amines correspondantes, et leurs applications biologiques.
US5408040A (en) * 1991-08-30 1995-04-18 University Of South Florida Connective tissue growth factor(CTGF)
IL105529A0 (en) * 1992-05-01 1993-08-18 Amgen Inc Collagen-containing sponges as drug delivery for proteins

Also Published As

Publication number Publication date
JP2004132974A (ja) 2004-04-30
US6069006A (en) 2000-05-30
MX9709294A (es) 1998-08-30
WO1996038172A1 (en) 1996-12-05
AU720268B2 (en) 2000-05-25
JPH11507332A (ja) 1999-06-29
US6150101A (en) 2000-11-21
BR9609521A (pt) 1999-06-15
US6232064B1 (en) 2001-05-15
AU5958296A (en) 1996-12-18
EP0831885A4 (de) 2000-11-29
EP0831903B1 (de) 2010-04-14
US5770209A (en) 1998-06-23
JP2007051150A (ja) 2007-03-01
CN1195295A (zh) 1998-10-07
CA2222509C (en) 2012-12-04
AU5885596A (en) 1996-12-18
AU722919B2 (en) 2000-08-17
EP0831903A4 (de) 2001-02-28
DE69638162D1 (de) 2010-05-27
WO1996038168A1 (en) 1996-12-05
CN1191491A (zh) 1998-08-26
CA2222609A1 (en) 1996-12-05
SG108208A1 (en) 2005-01-28
EP0831903A1 (de) 1998-04-01
JPH11506449A (ja) 1999-06-08
EP0831885A1 (de) 1998-04-01
CA2222509A1 (en) 1996-12-05
BR9608558A (pt) 1999-11-30

Similar Documents

Publication Publication Date Title
DE69638162D1 (de) Bindegewebs wachstumsfaktor (ctgf)
ATE181572T1 (de) Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
AU2001294541A1 (en) Mammalian genes; related reagents and methods
WO1998050554A3 (en) Enterococcus faecalis polynucleotides and polypeptides
FI961251A0 (fi) Ihmisten metabotrooppiset glutamaattireseptorialatyypit(HMR4, HMR6, HMR7)ja niihin liittyvät DNA-yhdisteet
MY157028A (en) Mammalian cytokine, related reagents
SE9500023D0 (sv) Method of detecting cancer
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
NO20030495D0 (no) Peptider som presenteres av celler
WO2000042188A3 (en) Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
BR9713450A (pt) Quimiocinas de mamìfero
WO1999046379A3 (en) Human receptor proteins; related reagents and methods
WO1998032858A3 (en) Mammalian chemokines; receptors; reagents; uses
EP1655382A3 (de) Dickdarm spezifisches Gen und Protein
WO1998031810A3 (en) Mammalian chemokines; receptors; reagents; uses
DE69734199D1 (de) Menschliches netrin-1
MX9603266A (es) Genes de timocina de mamiferos.
EP0780472A3 (de) Stress Proteine
MX9206732A (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas de tierra.
BR9911609A (pt) Proteìnas e genes de moraxella catarrhalis, antìgenos, anticorpos e usos
ATE407944T1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
WO1998041538A3 (en) Novel human cytokine/steroid receptor protein
EP0854186A3 (de) Zellteilungs-Gen DivIB von Staphylococcus aureus
WO1999019480A3 (en) Human receptor proteins; related reagents and methods

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties